Medico Remedies (NSE:MEDICO) Accounts Payable: ₹493 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MEDICO Medico Remedies Ltd NSE:MEDICO
85 GF Score
Price ₹38.81
GF Value ₹76.55
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medico Remedies Accounts Payable?

Medico Remedies NSE:MEDICO -0.15% 85 Accounts Payable is ₹493 Mil as of Mar. 2026. GuruFocus rates NSE:MEDICO with a GF Score™ of 85/100 and a GF Value™ of ₹76.55 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Medico Remedies's Accounts Payable for the quarter that ended in Mar. 2026 was ₹493 Mil.

Medico Remedies's quarterly Accounts Payable declined from Sep. 2025 (₹536 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹493 Mil).

Medico Remedies's annual Accounts Payable increased from Mar. 2024 (₹315 Mil) to Mar. 2025 (₹347 Mil) and increased from Mar. 2025 (₹347 Mil) to Mar. 2026 (₹493 Mil).

Medico Remedies Accounts Payable Related Terms

Medico Remedies Accounts Payable Historical Data

* Premium members only.

The historical data trend for Medico Remedies's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medico Remedies Accounts Payable Chart

Medico Remedies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 270.97 309.86 315.12 347.13 493.28

Medico Remedies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 347.13 0.00 536.06 0.00 493.28
NSE:MEDICO
85GF Score
Medico Remedies Ltd NSE:MEDICO
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medico Remedies Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹493 Mil mean?
Medico Remedies (NSE:MEDICO) has a Accounts Payable of ₹493 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Medico Remedies and its competitors.
Is Medico Remedies' Accounts Payable too high?
Medico Remedies' current Accounts Payable is ₹493 Mil. Overall, Medico Remedies has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medico Remedies' Accounts Payable compare to ZTS and UTHR?
Medico Remedies' Accounts Payable of ₹493 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Medico Remedies and its competitors. Medico Remedies's current Accounts Payable is ₹493 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medico Remedies stock overvalued right now?
Based on GuruFocus' analysis, Medico Remedies (NSE:MEDICO) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹76.55, compared to a current price of ₹38.81 — trading 49.3% below its estimated fair value. The current Accounts Payable is ₹493 Mil. Medico Remedies' overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Medico Remedies (NSE:MEDICO), the current Accounts Payable is ₹493 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medico Remedies (NSE:MEDICO) Overvalued in 2026?

Based on GuruFocus' analysis, Medico Remedies stock appears to be undervalued. The current stock price of ₹38.81 is trading 49.3% below its estimated GF Value™ of ₹76.55. GuruFocus considers Medico Remedies to be Significantly Undervalued.

Key valuation signals for NSE:MEDICO:

  • Accounts Payable: ₹493 Mil
  • GF Value™: ₹76.55 vs. price of ₹38.81 (49.3% below fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the NSE:MEDICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medico Remedies Business Description

Other Exchanges 540937:India
Address N. S. Phadke Marg, Opposite Teligali, 1105/1106, 11th Floor, Hubtown Solaris, Andheri (East), Mumbai, MH, IND, 400069
Medico Remedies Ltd is a manufacturer, supplier, and exporter of pharmaceutical drugs. It operates in single segment single segment of manufacturing medicines including Antihy pertensive Antidiabetics Antibictics Diuretics, Antimalarials, NSAIDS Tablets, Antireterovirals, Anti-Ulcer Drugs and Antacids Tablets, so many drugs used for treatment of so many diseases for oral use as well as external preparations like creams & ointments which includes anti infectives ,antifungals ,antibiotics ,steroidal preparations etc. In addition, it also sells other drugs such as antihistaminic, antidiabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments.
85GF Score

Get the complete analysis for NSE:MEDICO

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹38.81
Price
₹76.55
GF Value